Creatinine Clearance in Obesity

In obesity, putting total body weight into Cockcroft–Gault overestimates creatinine clearance. Extra body weight in obesity is mostly fat, which produces little creatinine, so the formula credits the kidneys with clearance the patient does not have.

Why Total Body Weight Inflates the Estimate

Cockcroft–Gault multiplies by weight because, in an average build, weight tracks muscle mass, and muscle is what produces creatinine. In obesity that link breaks: most of the excess weight is adipose tissue, which is metabolically quiet and generates almost no creatinine. Feeding the full weight into the formula therefore rewards the kidneys for muscle that isn't there. A 150 kg patient might calculate a clearance 40–50% higher than reality on total body weight — a gap large enough to overdose a renally-cleared drug if it goes unchecked.

Which Weight to Use

For most patients, use adjusted body weight, which adds a fraction (about 0.4) of the excess weight to ideal body weight — capturing the modest amount of extra lean tissue that does come with obesity while discarding the inert fat. As a guide:

• Actual weight below ideal — use actual weight.
• Roughly ideal — use actual (total) weight.
• Obese (actual more than about 1.2× ideal) — use adjusted body weight.

For example, a patient with an ideal weight of 60 kg who actually weighs 110 kg is well above the 1.2× threshold (72 kg), so adjusted body weight — roughly 60 + 0.4 × (110 − 60) = 80 kg — is the dosing weight, not the full 110 kg.

What the Salazar–Corcoran Equation Adds

The Salazar–Corcoran equation was derived specifically in obese patients and folds height and weight into the formula directly, so it does not require the clinician to first decide which weight to plug in. That removes a step where errors creep in. It is most useful when obesity is marked — for instance a body mass index well above 30 — and is a reasonable alternative to running Cockcroft–Gault with an adjusted weight. Whichever route is taken, the two methods should land in a similar range; a large discrepancy is a prompt to re-check the inputs.

Lean Body Weight as Another Option

Some clinicians prefer lean body weight, which estimates the muscle-bearing mass directly and is well suited to obesity because creatinine production tracks lean tissue. Whichever weight is chosen, the goal is the same: feed the formula the mass that actually makes creatinine, not the mass on the scale. Document which weight you used, since the choice meaningfully changes the dose.

Why the Choice of Weight Changes the Dose

The weight you feed the formula flows straight through to the clearance and then to the drug dose, so the decision is not academic. Using total body weight instead of adjusted body weight in a markedly obese patient can inflate the calculated clearance by a third or more, which for a renally-cleared antibiotic or anticoagulant could mean a dose that is too high and accumulates. Because the gap is large, guidelines and many drug labels specify which weight to use, and documenting the weight chosen makes the dose reproducible for the next clinician. When the calculated value and the patient's clinical response disagree, trust the patient and re-examine the inputs.

Calculate with the appropriate weight using the creatinine clearance calculator, and confirm renally-cleared drug doses against the patient's clinical response. Where an accurate value is critical, a measured creatinine clearance or a cystatin C–based estimate can settle a doubtful case, since cystatin C does not depend on muscle mass and sidesteps the weight question altogether.